CCN4 and breast carcinoma: In developing state metrics that quantify functional plasticity in breast cancer and melanoma using an unsupervised approach, CCN4 was the only gene product associated with both a mesenchymal state metric in breast cancer and a de-differentiated state metric in melanoma that results in a secreted protein21.